Выбор редакции
26 мая 2017, 16:42

Merck (MRK) Buys Rights to Anti-tau Antibody for Alzheimer

Merck & CO, Inc. (MRK) announced that it has bought exclusive worldwide license from Teijin Pharma for the development, manufacture and commercialization of an investigational preclinical anti-tau antibody.

26 мая 2017, 15:08

Pharma Stock Roundup: Label Expansion for Merck Drug, Aerie Up On Eye Data

Merck (MRK) got another approval for Keytruda while Aerie shot up on positive data.

Выбор редакции